Cargando…
Diagnostic criteria, specific mutations, and genetic predisposition in gastrointestinal stromal tumors
In 1998, gastrointestinal stromal tumor (GIST) emerged as a distinct oncogenetic entity and subsequently became a paradigm of targeted therapies in solid tumors. Diagnosis of GIST relies on both histology and immunohistochemistry. Ninety-five percent of GISTs express either KIT or DOG-1. Approximate...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681166/ https://www.ncbi.nlm.nih.gov/pubmed/23776354 http://dx.doi.org/10.2147/TACG.S7191 |